Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Cytogenetics

FISH BCL6 3q27 Gene Rearrangement Test

The FISH BCL6 3q27 Gene Rearrangement Test identifies genetic changes in the BCL6 gene linked to certain cancers, particularly lymphomas. This test helps guide treatment decisions for oncologists and hematologists.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Formalin fixed paraffin embedded tissue block (must contain 10% tumor tissue), 4 mL (3 mL min.) whole blood, or 4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube.
Results
Results are typically available within four working days after sample receipt.
Preparation
Confirm with the laboratory before booking. Ensure the correct sample type is collected and labelled appropriately. A duly filled Chromosome & FISH analysis Requisition Form (Form 17) is required.
Test priceKSh 14,040

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FISH BCL6 3q27 Gene Rearrangement Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Diagnosis of suspected lymphoma
  • ✓Prognosis assessment in certain cancers
  • ✓Guiding treatment decisions
  • ✓Monitoring disease progression
  • ✓Identifying specific genetic alterations linked to cancer
02

In plain language

What this test helps you understand

This test helps identify specific genetic rearrangements in the BCL6 gene, which can aid in the diagnosis, prognosis, and treatment planning for certain cancers, especially lymphomas.
The FISH BCL6 3q27 Gene Rearrangement Test is an advanced diagnostic tool used to identify specific genetic alterations associated with various types of cancers. This test utilizes Fluorescence In Situ Hybridization (FISH) technology to detect rearrangements of the BCL6 gene, which are often associated with certain hematological malignancies. Understanding these genetic changes is crucial for healthcare providers in tailoring effective treatment plans. This test specifically measures the rearrangement of the BCL6 gene located on chromosome 3q27. The presence of these rearrangements can indicate the likelihood of specific cancer types, particularly lymphomas, and can influence the choice of therapeutic strategies.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Ensure the correct sample type is collected and labelled appropriately. A duly filled Chromosome & FISH analysis Requisition Form (Form 17) is required.
SampleFormalin fixed paraffin embedded tissue block (must contain 10% tumor tissue), 4 mL (3 mL min.) whole blood, or 4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube.
MethodologyFluorescence In Situ Hybridization (FISH)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific rearrangements of the BCL6 gene. It may not detect all types of genetic alterations associated with cancer. Results should be interpreted in conjunction with other clinical and laboratory findings.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test uses FISH technology to detect rearrangements in the BCL6 gene, which are linked to certain types of cancer, especially lymphomas.
Identifying BCL6 gene rearrangements helps doctors diagnose cancer, understand its potential behavior, and choose the most effective treatment plan.
The test can be performed on formalin-fixed paraffin-embedded tissue, whole blood, or bone marrow samples. Confirm specific requirements with the lab.
Results are generally available within four working days from the time the sample is received by the laboratory.
A positive result indicates the presence of BCL6 gene rearrangement. Your doctor will interpret this result in the context of your overall health and other test findings.
You can book the test by calling or WhatsApping us at +254711564616. We have branches across Kenya and offer home sample collection.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Catecholamines Plasma Test

Measures epinephrine and norepinephrine levels in plasma to help detect hormonal imbalances related to conditions like hypertension and anxiety. Confirm with the laboratory before booking.

Learn more →

Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test

Detects Epstein-Barr Virus (EBV) RNA in tumor tissue to aid in the early diagnosis of EBV-related cancers like lymphomas and nasopharyngeal carcinoma.

Learn more →

CA Cyfra 211 Lung Cancer Marker Test

The CA Cyfra 21-1 Lung Cancer Marker Test measures a specific protein fragment in the blood that can be elevated in lung cancer. It aids in diagnosis and monitoring.

Learn more →

Breast Cancer ER PR HER2 Ki67

The Breast Cancer ER PR HER2 Ki67 test analyzes key markers in breast tumor tissue to guide personalized treatment decisions. It measures hormone receptors (ER, PR), HER2 protein, and the Ki-67 proliferation marker.

Learn more →
Chat on WhatsApp